These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12773918)

  • 41. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders.
    Kovács P; Mátyás S; Kaali SG
    Fertil Steril; 2006 Apr; 85(4):913-7. PubMed ID: 16580374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian hyperstimulation syndrome.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S178-83. PubMed ID: 17055817
    [No Abstract]   [Full Text] [Related]  

  • 44. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro fertilization in the PCOS patient: clinical considerations.
    Jabara S; Coutifaris C
    Semin Reprod Med; 2003 Aug; 21(3):317-24. PubMed ID: 14593555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study on ovarian hyperstimulation syndrome].
    Chen G
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):645-6. PubMed ID: 11930685
    [No Abstract]   [Full Text] [Related]  

  • 47. Ovarian hyperstimulation syndrome: an important complication of in vitro fertilization.
    Justice HM; Counselman FL
    Am J Emerg Med; 2008 Jan; 26(1):115.e3-4. PubMed ID: 18082809
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].
    Olivennes F
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S24-6. PubMed ID: 15643682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of populations of granulosa cells from individual follicles in women undergoing 'coasting' during controlled ovarian stimulation (COS) for IVF.
    Tozer AJ; Iles RK; Iammarrone E; Nica RA; Gillott CM; Xusong W; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Nov; 19(11):2561-8. PubMed ID: 15471924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleural effusion after in-vitro fertilization: consider ovarian hyperstimulation.
    Sohan K; Ramsewak SS
    West Indian Med J; 2004 Sep; 53(4):265. PubMed ID: 15624248
    [No Abstract]   [Full Text] [Related]  

  • 52. Late presentation with severe ovarian hyperstimulation syndrome is diagnostic of clinical in vitro fertilization pregnancy.
    Richter KS; Van Nest RL; Stillman RJ
    Fertil Steril; 2004 Aug; 82(2):478-9. PubMed ID: 15302307
    [No Abstract]   [Full Text] [Related]  

  • 53. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study.
    D'Angelo A; Davies R; Salah E; Nix BA; Amso NN
    Fertil Steril; 2004 Feb; 81(2):332-6. PubMed ID: 14967369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can we eliminate severe ovarian hyperstimulation syndrome? Comment 2.
    De Neubourg D; Gerris J
    Hum Reprod; 2005 Aug; 20(8):2369; author reply 2369-70. PubMed ID: 16024547
    [No Abstract]   [Full Text] [Related]  

  • 55. Human albumin does not prevent ovarian hyperstimulation syndrome in assisted reproductive technology program: a prospective randomized placebo-controlled double blind study.
    Isikoglu M; Berkkanoglu M; Senturk Z; Ozgur K
    Fertil Steril; 2007 Oct; 88(4):982-5. PubMed ID: 17313946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
    Antoine JM; Verstraete L
    Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombosis post ovarian hyperstimulation.
    Chipwete SE; Bugren S; Rafla N
    Fertil Steril; 2009 May; 91(5):1956.e13-4. PubMed ID: 19261273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.
    Arslan M; Bocca S; Mirkin S; Barroso G; Stadtmauer L; Oehninger S
    Fertil Steril; 2005 Sep; 84(3):555-69. PubMed ID: 16169382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?
    García-Velasco JA; Isaza V; Quea G; Pellicer A
    Fertil Steril; 2006 Mar; 85(3):547-54. PubMed ID: 16500317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Falling estradiol levels as a result of intentional reduction in gonadotrophin dose are not associated with poor IVF outcomes, whereas spontaneously falling estradiol levels result in low clinical pregnancy rates.
    Fisher S; Grin A; Paltoo A; Shapiro HM
    Hum Reprod; 2005 Jan; 20(1):84-8. PubMed ID: 15489238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.